Skip to main

Designation of Adalimumab (Humira) as an orphan drug by Abbvie Pty Ltd

Administered by
  • Department of Health, Disability and Ageing

This item is authorised by the following title:

Latest version
C2015G0017304 February 2015

Legislation text